June 9 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX
* Seeks trading halt pending an announcement of results from promarkerd clinical validation study Source text for Eikon: ID:nASXc6tZfh Further company coverage: PIQ.AX
June 9 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX
* Seeks trading halt pending an announcement of results from promarkerd clinical validation study Source text for Eikon: ID:nASXc6tZfh Further company coverage: PIQ.AX